Pylarify

Active Awarded Last action

Contract number
36C25726A0014
Awardee
Awarding agency
Task orders
1 $1,940,665 obligated

Award facts

Combined order value
$1,940,665 Current and potential, with all options
Last date to order 16% complete
IDV ceiling 21% used
$9,071,800.00
Maximum order
$2,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This Blanket Purchase Agreement, awarded January 6, 2026, to Progenics Pharmaceuticals Inc. (operating as a division of Lantheus Medical Imaging, Inc.) by Veterans Integrated Service Network 17, establishes a single-award indefinite delivery vehicle for the procurement of PYLARIFY (piflufolastat F-18), a diagnostic radiopharmaceutical imaging agent. The contract, valued at $9,071,800 and extending through January 4, 2031, operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) on a firm fixed-price basis. PYLARIFY is a radioactive positron emission tomography (PET) diagnostic agent utilized for the detection, localization, and imaging of prostate cancer in federal healthcare settings. Performance occurs primarily at Progenics' manufacturing and distribution facility in North Billerica, Massachusetts. No set-aside designation applies to this procurement, and the contract is structured to support ongoing radiopharmaceutical supply requirements across Veterans Health Administration medical centers within VISN 17's service area.

The associated task order, issued January 6, 2026, represents a $1,814,360 delivery order call with completion by January 4, 2027, demonstrating the operational mechanics through which VISN 17 draws down against the master BPA vehicle to fulfill immediate medical imaging support requirements. This BPA structure enables the Department of Veterans Affairs to maintain cost certainty through firm fixed-price arrangements while maintaining procurement flexibility for critical nuclear medicine supplies supporting prostate cancer diagnostic initiatives across the veteran population. Progenics maintains an extensive federal contracting presence through multiple BPAs with individual Veterans Integrated Service Networks, positioning itself as a primary supplier of specialized diagnostic radiopharmaceuticals to the federal healthcare system.

Task orders

Task order Ordering agency Obligated Awarded
Pylarify 36C25726N0177 Veterans Integrated Service Network 17 (VHA) $1,940,665

Quick answers

Who was awarded contract 36C25726A0014?

36C25726A0014 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on January 6, 2026.

How much is contract 36C25726A0014 worth?

Orders under 36C25726A0014 have obligated $1,940,665. 36C25726A0014's own ceiling is $9,071,800. A single order can be worth up to $2,000,000.

How many orders have been placed under contract 36C25726A0014?

1 order has been placed under 36C25726A0014, the latest on January 6, 2026.

Who can order from contract 36C25726A0014?

36C25726A0014 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36C25726A0014 under another contract?

Yes. 36C25726A0014 is a blanket purchase agreement under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25726A0014 competed?

The extent of competition for 36C25726A0014 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV